Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

Completed · Phase 4

Conditions studied: Schizophrenia

In brief

This study will determine the effectiveness of various combinations of psychosocial therapy and risperidone treatment in improving work or school performance in people with first-episode schizophrenia.

Key facts

Study ID

NCT00333177

Run by

University of California, Los Angeles

People needed

92

Starts

2006-03-01

Expected to finish

2013-01-01

Last updated by the study team

2020-03-26

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of schizophrenia, schizoaffective disorder (depressed type), or schizophreniform disorder
• First major episode of psychotic symptoms occurred within 2 years prior to study entry

You may not qualify if…

• Neurological disorder or injury (e.g., encephalitis, epilepsy, traumatic brain injury)
• Mental retardation (e.g., premorbid intelligence quotient (IQ) less than 70)
• Significant alcohol or substance use during last 6 months
• Unable to complete research measures in English
• Any condition that may make risperidone use medically inadvisable

Where it is running

• Semel Institute for Neuroscience and Human Behavior at UCLA — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.